Riskpilot← Back to searchSign inGet full accessKorman Kroksgård Medical AB
ABActiveOrg 5592733744Kadettstigen 13Medical specialists activities · NACE 8622Est. 20200 employees
Revenue 2025
SEK 143K
+18% vs 2024
EBITDA margin
81.9%
+8% vs 2024
Equity ratio
99.8%
Financial strength
Net profit 2025
SEK 93K
+8% vs 2024
| Revenue | SEK 143K | +18% |
| EBITDA | SEK 117K | +8% |
| Net profit | SEK 93K | +8% |
| Total assets | SEK 143K | -16% |
| Equity | SEK 142K | +27% |
| Employees | 0 | — |
Legal name
Korman Kroksgård Medical AB
Org number
5592733744
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 september 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkar- och sjuksköterskebemanning och därtill förenlig verksamhet. Utbildning och konsultverksamhet inom medicin, hälsa och därtill förenlig verksamhet. Läkar- och sjuksköterkearbete vid idrottsevenemang. Medicintekniskt utvecklingsarbete. Handel med värdepapper samt annan därtill förenlig verksamhet.
Address
Kadettstigen 13
Email
david.korman@hotmail.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 115 | 163 | 194 | 122 | 143 |
| Staff expenses | — | −8 | −7 | −4 | −7 |
| EBITDA | 89 | 125 | 144 | 109 | 117 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 89 | 125 | 144 | 109 | 117 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | 89 | 125 | 144 | 110 | 118 |
| Tax | −19 | −26 | −30 | −23 | −25 |
| Net profit | 70 | 99 | 114 | 87 | 93 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 138 | 228 | 311 | 169 | 143 |
| Equity | 95 | 124 | 139 | 112 | 142 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 43 | 104 | 171 | 57 | 0 |
| Total debt | 43 | 104 | 171 | 57 | 0 |
EBITDA margin
81.9%
This company
15.8%
Market median
+418% vs market
20212025
Equity ratio
99.8%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
65.7%
This company
18.4%
Market median
+257% vs market
20212025
Net profit margin
65.1%
This company
8.1%
Market median
+704% vs market
20212025
Asset turnover
1.01×
This company
1.12×
Market median
+10% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DO Chief Executive Officer | Chief Executive Officer | 2022 |
JB Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Korman Kroksgård Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Otto Emanuel Korman | Chief Executive Officer | 0 companies |
| Jenny Birgitta Korman Kroksgård | Deputy Chief Executive Officer | 0 companies |